The Trp64Arg polymorphism of the β3-adrenergic receptor gene: Lack of association with NIDDM and features of insulin resistance syndrome

Diabetes Care

Volumn 20, Issue 8, 1997, Pages 1319-1323

  Rissanen, Johanna ^a   Kuopusjärvi, Marja ^a   Pihlajamäki, Jussi ^a   Sipiläinen, Raisa ^a   Heikkinen, Sami ^a   Vanhala, Mauno ^b   Kekäläinen, Päivi ^a   Kuusisto, Johanna ^a   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Pieksämäki Health Center   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR;

ADULT; ARTICLE; FINLAND; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HORMONE RECEPTOR INTERACTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 1842416502     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.8.1319     Document Type: Article

References (37)

1. Reaven GM: Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37 1595-1607, 1988
2. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
3. Barrett-Connor E: Epidemiology, obesity, and non-insulin-dependent diabetes mellitus. Epidemiol Rev 11:172-181, 1989
4. Knowler WC, Pettitt DJ, Saad MF, Charles MA, Nelson RG, Howard BV, Bogardus C, Bennett PH: Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr 53 (Suppl):1543S-1551S, 1991
5. McCarthy M, Hitman GA: The genetic aspects of non-insulin-dependent diabetes mellitus. In Causes of Diabetes: Genetic and Environmental Factors. Leslie RDG, Ed. New York, Wiley, 1993, p. 157-183
6. Martin BC, Warram JH, Rosner B, Rich SS, Soeldner JS, Krolewski AS: Familial clustering of insulin sensitivity. Diabetes 41:850-854, 1992
7. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329-1335, 1987
8. Laws A, Stefanick M, Reaven G: Insulin resistance and hypertriglyceridemia in non-diabetic relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:343-347, 1989
9. Bogardus C, Lillioja S, Ravussin E, Abbott W, Zawadzki JK, Young A, Knowler WC, Jacobowitz R, Moll PP: Familial dependence of the resting metabolic rate. N Engl J Med 315:96-100, 1986
10. Bouchard C, Tremblay A, Nadeau A, Després JP, Thériault G, Boulay MR, Lortie G, Leblanc C, Fournier G: Genetic effect in resting and exercise metabolic rates. Metabolism 38:364-370, 1989
11. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
12. 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci 15:3-7, 1994
13. 3 and atypical badrenoceptors. Med Res Rev 13:663-729, 1993
14. 3-adrenoceptor in man. Br J Pharmacol 110:929-936, 1993
15. 3-adrenoceptors in obesity. J Clin Invest 95:1109-1116, 1995
16. Colberg SR, Simoneau J-A, Thaete FL, Kelley DE: Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1846-1853, 1995
17. 3-adrenergic-receptor gene. N Engl J Med 333:343-347, 1995
18. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
19. 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 39:349-352, 1996
20. De la Chapelle A: Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 30:857-865, 1993
21. Sarlund H, Pyörälä K, Penttilä I, Laakso M: Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin dependent diabetes. Arterioscler Thromb 12:657-663, 1992
22. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
23. Haffner SM, Karhapää P, Mykkänen L, Laakso M: Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 43:212-219, 1994
24. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol 237:E214-E223, 1979
25. Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Deeb SS: Insulin receptor substrate1 variants in non insulin-dependent diabetes. J Clin Invest 94:1141-1146, 1994
26. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocrinol Rev 5:45-86, 1985
27. Takala J, Keinänen O, Väisänen P, Kari A: Measurement of gas exchange in intensive care: laboratory and clinical validation of a new device. Crit Care Med 17:1041-1047, 1989
28. Laakso M, Uusitupa M, Takala J, Majander H, Reijonen T, Penttilä I: Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism 37:1092-1100, 1988
29. Ferrannini E: The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301, 1988
30. Hawk PB, Oser BL, Summerson WH: Practical Physiological Chemistry. 12th ed. Toronto, Blakiston, 1947, p. 814-822
31. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354, 1995
32. 3-adrenergic receptor gene. Diabetes 45:1115-1120, 1996
33. 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857-860, 1996
34. 3-adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 98:2086-2093, 1996
35. -adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 46:77-80, 1997
36. 2-adrenergic receptor: how structure elucidates function. Annu Rev Pharmacol Toxicol 32:167-183, 1992
37. 3-adrenergic receptor mutant. Endocrinology 137:2638-2641, 1996